BNGO
BNGO
NASDAQ · Life Sciences Tools & Services

Bionano Genomics Inc

$1.00
-0.04 (-3.85%)
As of Nov 14, 2:46 AM ET ·
Financial Highlights (FY 2026)
Revenue
74.44M
Net Income
-68,926,255
Gross Margin
46.2%
Profit Margin
-92.6%
Rev Growth
+0.8%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 74.44M 73.82M 4.56M 4.59M
Gross Profit 34.43M 34.14M 1.38M 1.39M
Operating Income -87,061,187 -77,702,368 710.4K 800.1K
Net Income -68,926,255 -61,516,887 617.9K 580.5K
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Rev Growth +0.8% +0.8% +4.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 550.3K 550.3K 5.02M 4.32M
Total Equity 6.56M 6.56M 5.58M 6.22M
D/E Ratio 0.08 0.08 0.90 0.70
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -72,957,238 -68,732,027 871.5K 857.6K
Free Cash Flow — — 406.9K 381.9K